Contract award · 10 Oct 2025

Human Papillomavirus (2025)

UK Health Security Agency awarded “Human Papillomavirus (2025)” to Merck Sharpe and Dohme (UK) Limited for £1. Awarded without open competition.

No competitionMedical equipment & pharmaceuticalsLondon

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Value
£1
Procedure
Negotiated procedure without prior publication (above threshold)
Sector
Medical equipment & pharmaceuticals · Vaccines (CPV 33651600)
Region
London
Timeline
  1. Contract date10 Oct 2025
  2. Published16 Oct 2025Published 6 days after the contract date

Description

Contract for the supply of human papillomavirus vaccine to be used as part of the national immunisation programme. Deliveries will be required for a four year period from December 2025 Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
10 Oct 2025 Merck Sharpe and Dohme (UK) Limited £1

More from UK Health Security Agency

All contracts

More won by Merck Sharpe and Dohme (UK) Limited

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview